Biotech megarounds ga­lore; New lead­ers at No­var­tis, Bio­gen; State of play for GLP-1 in NASH; In­side Il­lu­mi­na’s CEO search; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

De­spite a short­er week, we still saw biotech news come back in full force for Sep­tem­ber, par­tic­u­lar­ly on the fi­nanc­ing and peo­ple front — with Il­lu­mi­na fi­nal­ly mak­ing its CEO pick, in ad­di­tion to No­var­tis and Bio­gen nam­ing new lead­ers as part of a big­ger vi­sion. At End­points, we were ex­cit­ed to wel­come Ay­isha Shar­ma to the Lon­don team.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER